Search
Menu

A New Era in Blood Testing: Raman Spectroscopy in Point-of-Care Diagnostics

Oct 16, 2024
Facebook X LinkedIn Email
TO VIEW THIS WEBINAR:
Login  Register
Sponsored by
Oxford Instruments WITec
Avantes BV
About This Webinar
Raman spectroscopy is being applied to blood diagnosis in new and innovative ways. Blood diagnostics provide prompt and precise information about an individual's health and medical conditions, which is particularly beneficial in the case of severe infectious diseases. Effective pathogen characterization, optimal antibiotic selection, and modulation of the host response are interconnected factors that should be considered together rather than separately. It is essential that medical professionals are able to categorize patients and streamline the process of collecting samples.

This has led to the development of new diagnostic techniques that, when combined with appropriate sample processing, sensors, and data analysis, provide clinicians with valuable information to help them choose the most appropriate treatment options. Photonic diagnostics have proven effective in making time-sensitive judgments and have the potential to be used at the patient's bedside. Lab-based tests utilizing in-vitro Raman-based diagnostics are being employed in sample-to-answer workflows for microbiological diagnostics and host response in clinical settings, and blood tests are demonstrating this concept.

*** This presentation premiered during the 2024 BioPhotonics Conference. For more information on Photonics Media conferences and summits, visit events.photonics.com

About the presenter

Jürgen PoppJürgen Popp, Ph.D., studied chemistry at the University of Erlangen-Nuremburg and the University of Würzburg in Germany. After finishing his doctorate in chemistry, he joined Yale University for postdoctoral work. He subsequently returned to the University of Würzburg, where he finished his habilitation in 2002. Since 2002, Popp has held a chair for physical chemistry at the Friedrich-Schiller University Jena in Germany. Since 2006, he has also been the scientific director of the Leibniz Institute of Photonic Technology in Jena.

Popp is a world-leading expert in biophotonics and optical health technology research, covering the complete range from basic photonics research to translation into clinically applicable methods. He has published more than 960 journal papers, has been named as an inventor on 12 patents, and has given more than 200 invited talks on national and international conferences, among them more than 50 were keynote/plenary lectures. In addition, he has organized numerous conferences and workshops, such as the world’s largest conference on Raman spectroscopy, ICORS, in 2014. He is editor-in-chief of the Journal of Biophotonics. Furthermore, he is a leading partner in various national and international projects in cooperation with academic, clinical, and industrial partners, and he has raised more than €50 million ($50 million) in third-party funding. He has been frequently asked to be a contact person for media and politics.

In 2012, he received an honorary doctoral degree from Babes-Bolyai University in Cluj-Napoca, Romania. Popp is the recipient of the 2013 Robert Kellner Lecture Award, and in 2016 he received the prestigious Pittsburgh Spectroscopy Award. Also in 2016, he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. In 2018, Popp was awarded the renowned Ioannes Marcus Marci Medal of the Czech Society for Mass Spectrometry, he won the third prize of the Berthold Leibinger Innovationspreis, and he received the Kaiser-Friedrich-Forschungspreis. In 2019, he was awarded the Ralf-Dahrendorf-Preis für den Europäischen Forschungsraum, and in 2020 he became an Optica senior fellow. In 2021, he became a Fellow of the Royal Society of Chemistry (FRSC).
spectroscopyBiophotonicsRaman spectroscopyblood testing
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.